Anca Vlasie, MD
Nephrology · Westlake, OHNPI 1184931032
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $196 of the $269 with a category attached, or 72.9%. 7 manufacturers reported payments, led by Baxter Healthcare at 30.5% of the total. Reporting peaked in 2019 at $159 and has fallen 59.9% since, to $64 in 2025. That places this record below the midpoint for nephrology clinicians in OH, where the typical reported total is $965.
Across 12 payments — averaging $22.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Baxter Healthcare$82
- Otsuka America Pharmaceutical, Inc.$77
- Vifor Pharma, Inc.$39
- Lilly USA, LLC$27
- Fresenius USA Marketing, Inc.$17
- Amgen$15
- plus $11 from 1 others
What the payments were for
- Food & beverage$19673%
- Education$7327%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Baxter Healthcare | 1 | $82 |
| Otsuka America Pharmaceutical, Inc. | 2 | $77 |
| Vifor Pharma, Inc. | 2 | $39 |
| Lilly USA, LLC | 1 | $27 |
| Fresenius USA Marketing, Inc. | 1 | $17 |
| Amgen | 1 | $15 |
| Travere Therapeutics, Inc. | 4 | $11 |
How this compares
$269 in reported general payments places this provider in the 20th percentile of 450 nephrology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LokelmaSodium Zirconium Cyclosilicate | 22 | $13,097 |
| FarxigaDapagliflozin Propanediol | 19 | $12,626 |
| DapagliflozinDapagliflozin Propanediol | 11 | $5,945 |
| Doxazosin Mesylate | 163 | $2,290 |
| Potassium Chloride | 67 | $1,941 |
| Sevelamer Carbonate | 15 | $1,741 |
| Calcitriol | 144 | $1,621 |
| Tamsulosin Hcl | 147 | $1,502 |
| Nifedipine ErNifedipine | 42 | $1,466 |
| Allopurinol | 191 | $1,387 |
| Potassium Citrate ErPotassium Citrate | 13 | $1,285 |
| Amlodipine Besylate | 255 | $904 |
| Candesartan Cilexetil | 11 | $849 |
| Hydralazine Hcl | 49 | $810 |
| Metoprolol Succinate | 58 | $804 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Westlake
- Arash RashidiWestlake$113K
- Brad RovinColumbus$379K
- Nissreen ElfadawyChardon$327K
- Andrew LazarBeachwood$315K
- Amit GovilCincinnati$298K
- Georges NakhoulCleveland$255K
- Sankar NavaneethanCleveland$253K
- Ibrahim AhmadKettering$232K
- Prabir Roy ChaudhuryCincinnati$205K
- Rupesh RainaAkron$163K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.